Advanced Disease (Phase I) Cancer Studies Currently Recruiting Participants at the University of Chicago Comprehensive Cancer Center

Study Number Title
Select
14473B Phase I Safety, Pharmokinetic and Pharmacodynamic Study of PF-02341066, A C-MET/HGFR Selective Tyrosine Kinase Inhibitor, Administered Orally to Patients with Advanced Cancer
Select
16802B Biological Endpoints in the Annihilation of Oligometastases (BEAM ON)
Select
10-487-A The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
16830A Communication Preferences, Expectations of Benefit, and Symptom Burdens Among Advanced Cancer Patients and Partners During Patient Participation in Phase I Trials
Select
10-652-B Vorinostat and Carboplatin in Patients with Advanced Solid Tumors: A Pharmacokinetic and Pharmacodynamic Study
Select
11-0514 A Phase 1 2 Study of the Safety, Tolerability, Pharmacokinetics and Preliminary AntiTumor Activity of the Oral ALK EGFR Inhibitor AP26113
Select
11-0713 A Phase Ib, Open-Label Pharmacokinetics and Safety Study of Hedgehog Pathway Inhibitor Vismodegib in Patients with Advanced Solid Malignancies Including Hepatocellular Carcinoma with Varying Degrees of Renal or Hepatic Function
Select
12-1169 A pharmacodynamic study of sirolimus in older children and adults with advanced solid malignancies
Select
12-1278 A Phase I Open-Label Dose Escalation Study of LJM716 Administered Intravenously in Patients with Squamous Cell Carcinoma of Head and Neck, or HER2 Overexpressing Metastatic Breast Cancer or Gastric Cancer
Select
12-1318 A Drug-Drug Interaction Study of Capecitabine and Celecoxib in Patients with Advanced Solid Malignancies
Select
12-1667 A Phase I Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of Anti-KIR (BMS-986015) Administered in Combination with Anti-PD-1 (BMS-936558) in Advanced Refractory Solid Tumors
13-0002 A Registry for Serial Imaging and Plasma Assessment in Advanced Solid Tumor Patients

To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.